This article was originally published in The Tan Sheet
There is "no strong evidence of reduced risk of total mortality or combined cardiovascular events in participants taking additional omega-3 fats," a systematic review of 89 studies published online by the British Medical Journal concludes. Lee Hooper, School of Medicine, University of East Anglia, Norwich, et al., analyzed 48 randomized controlled trials and 41 cohort studies and conclude there are "substantial variations" among the findings. "Neither RCTs nor cohort studies showed significantly increased risks of cancer or stroke with higher intake of omega-3, but there were too few events to rule out important events," the authors state. Current UK recommendations encouraging the general public to eat more oily fish "should continue at present, but the evidence should be reviewed regularly," Hooper et al. add. According to an accompanying editorial, "the review shows that the evidence for a reduction in cardiovascular events and mortality is less conclusive than we believed"...
You may also be interested in...
Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients
As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.